A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer ("PREDICT") - Baseline findings for CA125. Kaaks R, Cooley V, Mukama T, Teras LR, et al. Clin Cancer Res 2025 Apr 14. doi: 10.1158/1078-0432.CCR-24-1845.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kaaks R, Cooley V, Mukama T, Teras LR, et al. A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer ("PREDICT") - Baseline findings for CA125. Clin Cancer Res 2025 Apr 14. doi: 10.1158/1078-0432.CCR-24-1845.
PMID: 40227208